A citation-based method for searching scientific literature

Marlies Wijsenbeek, Vincent Cottin. N Engl J Med 2020
Times Cited: 112







List of co-cited articles
799 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Kevin R Flaherty, Athol U Wells, Vincent Cottin, Anand Devaraj, Simon L F Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser,[...]. N Engl J Med 2019
549
51

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
43

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
36

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
32

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Toby M Maher, Tamera J Corte, Aryeh Fischer, Michael Kreuter, David J Lederer, Maria Molina-Molina, Judit Axmann, Klaus-Uwe Kirchgaessler, Katerina Samara, Frank Gilberg,[...]. Lancet Respir Med 2020
201
32

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
28

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
27

The natural history of progressive fibrosing interstitial lung diseases.
Kevin K Brown, Fernando J Martinez, Simon L F Walsh, Victor J Thannickal, Antje Prasse, Rozsa Schlenker-Herceg, Rainer-Georg Goeldner, Emmanuelle Clerisme-Beaty, Kay Tetzlaff, Vincent Cottin,[...]. Eur Respir J 2020
73
32

Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Athol U Wells, Kevin R Flaherty, Kevin K Brown, Yoshikazu Inoue, Anand Devaraj, Luca Richeldi, Teng Moua, Bruno Crestani, Wim A Wuyts, Susanne Stowasser,[...]. Lancet Respir Med 2020
148
24

Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities.
Peter M George, Paolo Spagnolo, Michael Kreuter, Goksel Altinisik, Martina Bonifazi, Fernando J Martinez, Philip L Molyneaux, Elisabetta A Renzoni, Luca Richeldi, Sara Tomassetti,[...]. Lancet Respir Med 2020
78
30

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
483
23

What's in a name? That which we call IPF, by any other name would act the same.
Athol U Wells, Kevin K Brown, Kevin R Flaherty, Martin Kolb, Victor J Thannickal. Eur Respir J 2018
139
20

Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Christopher J Ryerson, Jeffrey L Myers, Michael Kreuter, Martina Vasakova, Elena Bargagli, Jonathan H Chung, Bridget F Collins, Elisabeth Bendstrup,[...]. Am J Respir Crit Care Med 2020
188
20

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
575
19

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.
Vincent Cottin, Nikhil A Hirani, David L Hotchkin, Anoop M Nambiar, Takashi Ogura, María Otaola, Dirk Skowasch, Jong Sun Park, Hataya K Poonyagariyagorn, Wim Wuyts,[...]. Eur Respir Rev 2018
169
18

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
932
16

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Jürgen Behr, Antje Prasse, Michael Kreuter, Johannes Johow, Klaus F Rabe, Francesco Bonella, Reiner Bonnet, Christian Grohe, Matthias Held, Heinrike Wilkens,[...]. Lancet Respir Med 2021
61
24

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
14

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
14

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Donald P Tashkin, Michael D Roth, Philip J Clements, Daniel E Furst, Dinesh Khanna, Eric C Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R Volkmann, Suzanne Kafaja,[...]. Lancet Respir Med 2016
455
13

Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management.
Marlies Wijsenbeek, Michael Kreuter, Amy Olson, Aryeh Fischer, Elisabeth Bendstrup, Christopher D Wells, Christopher P Denton, Baher Mounir, Leila Zouad-Lejour, Manuel Quaresma,[...]. Curr Med Res Opin 2019
66
19

Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
David A Lynch, Nicola Sverzellati, William D Travis, Kevin K Brown, Thomas V Colby, Jeffrey R Galvin, Jonathan G Goldin, David M Hansell, Yoshikazu Inoue, Takeshi Johkoh,[...]. Lancet Respir Med 2018
427
13

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study).
Mouhamad Nasser, Sophie Larrieu, Salim Si-Mohamed, Kaïs Ahmad, Loic Boussel, Marie Brevet, Lara Chalabreysse, Céline Fabre, Sébastien Marque, Didier Revel,[...]. Eur Respir J 2021
38
34

Cyclophosphamide versus placebo in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Jonathan Goldin, Michael D Roth, Daniel E Furst, Edgar Arriola, Richard Silver, Charlie Strange, Marcy Bolster,[...]. N Engl J Med 2006
976
12

Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study.
Lauren K Troy, Christopher Grainge, Tamera J Corte, Jonathan P Williamson, Michael P Vallely, Wendy A Cooper, Annabelle Mahar, Jeffrey L Myers, Simon Lai, Ellie Mulyadi,[...]. Lancet Respir Med 2020
142
12

Fibrosing interstitial lung diseases: knowns and unknowns.
Vincent Cottin, Lutz Wollin, Aryeh Fischer, Manuel Quaresma, Susanne Stowasser, Sergio Harari. Eur Respir Rev 2019
82
13

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Aryeh Fischer, Katerina M Antoniou, Kevin K Brown, Jacques Cadranel, Tamera J Corte, Roland M du Bois, Joyce S Lee, Kevin O Leslie, David A Lynch, Eric L Matteson,[...]. Eur Respir J 2015
489
11

Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease.
Joshua J Solomon, Jonathan H Chung, Gregory P Cosgrove, M Kristen Demoruelle, Evans R Fernandez-Perez, Aryeh Fischer, Stephen K Frankel, Stephen B Hobbs, Tristan J Huie, Jill Ketzer,[...]. Eur Respir J 2016
167
11

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
Pierre-Antoine Juge, Joyce S Lee, Esther Ebstein, Hiroshi Furukawa, Evgenia Dobrinskikh, Steven Gazal, Caroline Kannengiesser, Sébastien Ottaviani, Shomi Oka, Shigeto Tohma,[...]. N Engl J Med 2018
164
10

Prevalence and prognosis of unclassifiable interstitial lung disease.
Christopher J Ryerson, Thomas H Urbania, Luca Richeldi, Joshua J Mooney, Joyce S Lee, Kirk D Jones, Brett M Elicker, Laura L Koth, Talmadge E King, Paul J Wolters,[...]. Eur Respir J 2013
169
10

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease.
E J Kim, B M Elicker, F Maldonado, W R Webb, J H Ryu, J H Van Uden, J S Lee, T E King, H R Collard. Eur Respir J 2010
302
10

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Harold R Collard, Christopher J Ryerson, Tamera J Corte, Gisli Jenkins, Yasuhiro Kondoh, David J Lederer, Joyce S Lee, Toby M Maher, Athol U Wells, Katerina M Antoniou,[...]. Am J Respir Crit Care Med 2016
599
10

A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.
Christopher J Ryerson, Tamera J Corte, Joyce S Lee, Luca Richeldi, Simon L F Walsh, Jeffrey L Myers, Jürgen Behr, Vincent Cottin, Sonye K Danoff, Kevin R Flaherty,[...]. Am J Respir Crit Care Med 2017
98
10

Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey.
Amy Olson, Nadine Hartmann, Padmaja Patnaik, Laura Wallace, Rozsa Schlenker-Herceg, Mouhamad Nasser, Luca Richeldi, Anna-Maria Hoffmann-Vold, Vincent Cottin. Adv Ther 2021
17
58

Shared and distinct mechanisms of fibrosis.
Jörg H W Distler, Andrea-Hermina Györfi, Meera Ramanujam, Michael L Whitfield, Melanie Königshoff, Robert Lafyatis. Nat Rev Rheumatol 2019
146
9

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin E Hostettler, Susanne Stowasser, Martin Kolb. Eur Respir J 2015
393
9

Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study.
Ganesh Raghu, Kevin R Flaherty, David J Lederer, David A Lynch, Thomas V Colby, Jeffrey L Myers, Steve D Groshong, Brandon T Larsen, Jonathan H Chung, Mark P Steele,[...]. Lancet Respir Med 2019
57
14


Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Roland M du Bois, Elizabeth A Fagan, Robert S Fishman, Ian Glaspole, Marilyn K Glassberg, Lisa Lancaster,[...]. Eur Respir J 2016
229
8

Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype.
Yoshikazu Inoue, Robert J Kaner, Julien Guiot, Toby M Maher, Sara Tomassetti, Sergey Moiseev, Masataka Kuwana, Kevin K Brown. Chest 2020
33
24

The natural history of progressive fibrosing interstitial lung diseases.
Martin Kolb, Martina Vašáková. Respir Res 2019
79
10

Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
Ayodeji Adegunsoye, Justin M Oldham, Shashi K Bellam, Steven Montner, Matthew M Churpek, Imre Noth, Rekha Vij, Mary E Strek, Jonathan H Chung. Ann Am Thorac Soc 2019
44
18

Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis.
Andrea Gimenez, Karin Storrer, Lilian Kuranishi, Maria Raquel Soares, Rimarcs Gomes Ferreira, Carlos A C Pereira. Thorax 2018
65
12

Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
594
8

Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
Paola Faverio, Martina Piluso, Federica De Giacomi, Matteo Della Zoppa, Roberto Cassandro, Sergio Harari, Fabrizio Luppi, Alberto Pesci. Respiration 2020
16
50

Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
Clive A Kelly, Vadivelu Saravanan, Mohamed Nisar, Subha Arthanari, Felix A Woodhead, Alec N Price-Forbes, Julie Dawson, Navtej Sathi, Yasmeen Ahmad, Gouri Koduri,[...]. Rheumatology (Oxford) 2014
252
8

Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris.
Boris Duchemann, Isabella Annesi-Maesano, Camille Jacobe de Naurois, Shreosi Sanyal, Pierre-Yves Brillet, Michel Brauner, Marianne Kambouchner, Sophie Huynh, Jean Marc Naccache, Raphael Borie,[...]. Eur Respir J 2017
109
7

Predicting survival across chronic interstitial lung disease: the ILD-GAP model.
Christopher J Ryerson, Eric Vittinghoff, Brett Ley, Joyce S Lee, Joshua J Mooney, Kirk D Jones, Brett M Elicker, Paul J Wolters, Laura L Koth, Talmadge E King,[...]. Chest 2014
229
7

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Dinesh Khanna, Celia J F Lin, Daniel E Furst, Jonathan Goldin, Grace Kim, Masataka Kuwana, Yannick Allanore, Marco Matucci-Cerinic, Oliver Distler, Yoshihito Shima,[...]. Lancet Respir Med 2020
123
7

In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011.
John P Hutchinson, Andrew W Fogarty, Tricia M McKeever, Richard B Hubbard. Am J Respir Crit Care Med 2016
227
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.